lorlatinib will lessen the extent or impact of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Steer clear of utilization of lorlatinib with CYP3A substrates, where small concentration improvements could bring on really serious therapeutic failures from the substrate. Ergotamine: Alpha-adrenerg